SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001136261-20-000010
Filing Date
2020-01-07
Accepted
2020-01-07 16:32:01
Documents
1
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3881
  Complete submission text file 0001136261-20-000010.txt   5485
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 20513642